Ibogaine for veterans: the research, the programs and how we care for you

Line illustration of two dog tags hanging from a branch, with mountains and a rising sun

Programs and laws checked on 10 October 2026

Ibogaine has been studied in veterans only in small studies with no comparison group, mostly of male Special Operations veterans treated in Mexico. The most cited, from Stanford, reported large drops in disability, PTSD and depression a month later. As of October 2026, no VA, Defense Department or state study was enrolling veterans. At IbogaQuest, ibogaine is given only after a full medical evaluation, including an ECG.

If you are thinking about suicide, are in crisis now, or are worried about a veteran who is, the Veterans Crisis Line is free, confidential and open 24/7: dial 988 then press 1, or text 838255. Outside the US: in Canada, call or text 988.

The evidence at a glance – Studied in veterans: small, uncontrolled studies of selected men. – Controlled trials showing that ibogaine works: none, for any condition. – US programs enrolling veterans: none, as of October 2026. Related: ibogaine for PTSD and brain injury · what the research on ibogaine says

Jump to: Safety · Medicines · How we screen · Ask us

What does the research in veterans show?

In a study published in 2024, Stanford researchers followed 30 male Special Operations veterans, almost all with a mild traumatic brain injury (TBI). Each received a single oral dose of ibogaine with intravenous (IV) magnesium at a private clinic near Tijuana; IbogaQuest did not take part. One month later, their average score on a standard disability scale (WHODAS 2.0) had fallen from 30.2 to 5.1, and clinician-rated post-traumatic stress disorder (PTSD), depression and anxiety had fallen on average by at least 81%. The researchers reported no serious or unexpected side effects; everyone was unsteady and had a tremor for up to a day. (Cherian et al., Nature Medicine, 2024)

At 12 months, 25 of the 30 were assessed again and the improvements largely held, although most had also used other psychedelics or treatments during that year. (Faerman et al., Translational Psychiatry, 2026)

The study had no comparison group. Its participants were carefully selected men whose treatment a nonprofit paid for, and people with heart disease, psychosis or a current risk of suicide were not admitted. The authors themselves call for controlled trials. A plain summary: the Stanford paper, summarized.

The other published reports come from a program in Mexico that gave selected veterans, almost all men, ibogaine and then, two days later, a second psychedelic, 5-MeO-DMT. In online surveys, veterans reported less PTSD, depression and anxiety, but the effects of the two drugs cannot be separated. (Davis et al., 2023) Ibogaine is not an approved treatment for PTSD or brain injury, and the research is still small.

Does the VA offer or cover ibogaine?

No. Ibogaine is a Schedule I drug under US federal law. Outside an authorized research study it cannot be prescribed, and the VA cannot offer it as care. As of October 2026, no VA-run or VA-funded ibogaine study had been identified.

  • January 2026 · Department of Defense. Its psychedelic research program allows ibogaine, but its first two awards went to MDMA trials for PTSD.
  • April 2026 · Executive Order 14401. It directs the FDA and the DEA to create a Right to Try pathway that names ibogaine compounds. No document putting that pathway in place could be found as of 9 October 2026.
  • July 2026 · VA and HHS. The two departments agreed to cooperate on psychedelic trials; the VA’s announcement does not mention ibogaine. (VA release)

Whether treatment abroad affects your VA benefits is a question for your VA benefits office. More in is ibogaine legal?

Which states fund ibogaine research, and can veterans join a trial?

As of October 2026, no state program was enrolling anyone, and none is limited to veterans. Texas comes closest. Its 2025 law funds FDA drug-development trials of ibogaine, and the 50 million dollars it awarded in December 2025 include a brain-injury arm focused on veterans. But the state agency said the plans submitted did not yet meet the law’s requirements. (Texas HHSC)

Arizona, Kentucky, Mississippi, Tennessee and Louisiana have also passed laws that allow or fund ibogaine research; bills in Michigan and Missouri were pending. Status checked on 10 October 2026.

What should a veteran know about safety?

Every veteran’s heart is checked before treatment: a 12-lead ECG, blood tests and a review of every medicine you take, read independently by two physicians. Ibogaine acts on the heart as well as the brain, which is why that review comes first.

If you use opioids, including for chronic pain: tell us when you apply. Your tolerance to opioids is lower after ibogaine, and before you leave we go over what that means for you and give it to you in writing.

Whether ibogaine is right for you is a decision a medical team makes with you, after a full review. More on how we screen and care for you.

Which medicines need review before ibogaine?

Before you change any medicine. Our physicians review every medicine you take. Some may need a taper or a supervised detox first, planned with our medical team. Please don’t stop or cut down anything on your own. Antidepressants are tapered with your own prescriber, at the VA or in the community, and coming off some safely can take months. Whether and when to go back on your medicine is something you decide with your doctor; we give you guidance when you leave.

The medicines common in veteran care that need the most care with ibogaine:

  • antidepressants, above all paroxetine, fluoxetine and bupropion, which block the enzyme that clears ibogaine
  • medicines that lengthen the heart’s QT interval, such as methadone, buprenorphine, quetiapine and ondansetron
  • prazosin and other blood-pressure medicines
  • benzodiazepines and sleep medicines such as zolpidem, which are never stopped abruptly
  • ADHD stimulants

How does IbogaQuest screen and care for veterans?

Our protocol is, first of all, screening. Two physicians review every application independently: a 12-lead ECG from the last three months, blood tests, every medicine and substance you take, and your heart and psychiatric history. We decline people we cannot treat safely outside a hospital. We are registered with GITA. Since 2009 we have worked with people carrying trauma of many kinds, with depression and with alcohol dependence.

Who we accept. We accept veterans with PTSD and veterans with a mild traumatic brain injury. A moderate or severe brain injury does not rule you out: like other neurological conditions, it is reviewed case by case, and that review can include an assessment by a neurologist at a hospital near Tepoztlán.

Mental health. Before anyone is accepted, a certified clinical psychologist on our team carries out a psychological evaluation. A psychotic illness or bipolar disorder is not an automatic exclusion: our physicians review each case, with a report from your treating psychiatrist.

Medicines and substances. Strong blockers of that enzyme, such as paroxetine, fluoxetine or bupropion, rule you out until you have tapered them safely and finished the washout. If you take methadone or buprenorphine, the change is made well before the retreat, under our separate medically supported detox. We do a urine drug screen at intake, and for five days before arrival we ask you to avoid quinine (including tonic water), grapefruit and alcohol. If you drink every day or heavily up to the retreat, you first do a week of medical detox, with IV fluids and a detox protocol, as part of the program and with its own cost. After that you join the ibogaine retreat like everyone else. Tell us, and don’t stop drinking on your own. We don’t combine ibogaine with 5-MeO-DMT or any other psychedelic.

During the retreat. A nurse, a paramedic and two ibogaine providers stay on site day and night, and an ambulance with paramedics and a monitor-defibrillator stays on site. We give IV magnesium the day before the session. Unsteadiness is expected, so our staff help you each time you stand or walk until your balance returns. Our therapeutic team is with you throughout, and the program includes two one-hour group sessions for preparation and integration. How we watch the heart is explained in safety and medical screening. In an emergency, the ambulance takes you to a 24-hour private hospital in Cuernavaca, about 30 minutes away, with a member of our team.

Leaving and going home. Everyone stays for the full seven-day retreat. Before you leave, the team assesses you and our physician gives medical clearance. If you used opioids, we explain what the drop in tolerance means for you and give it to you in writing. If you ask us to, we coordinate with your therapist or physician when you go home.

More about the week itself: the treatment week, step by step.

Frequently asked questions

Is ibogaine a “cure” for PTSD or a brain injury?

No. The veteran studies report lower symptom scores in small groups of selected men, without a comparison group. Ibogaine is a treatment still under study.

Does ibogaine help with suicidal thoughts?

The studies can’t answer that yet, and the Stanford study left out people at current risk. Before anyone is accepted, a certified clinical psychologist on our team carries out a psychological evaluation. Suicidal thoughts, current or past, are always reviewed case by case: the psychologist assesses them, and she and our physicians decide together. Telling us does not close the door, and it does not open it on its own either. If you are having thoughts of suicide, or are worried about a veteran who is, tell someone: your own clinician if you have one, or the Veterans Crisis Line (dial 988 then press 1, or text 838255). Outside the US: in Canada, call or text 988.

Do you offer a discount for veterans?

Yes. Veterans and first responders receive $1,000 USD off the retreat price. Prices, what they include and how the deposit works are on our costs page.

Not sure whether a medicine, a past head injury or your history rules you out? {#ask-us} Ask us before you apply: contact us · US 1 (802) 748 4600 · MX +52 (777) 450 1946. Whenever you’re ready: apply.

Sources

  • Cherian KN, et al. Magnesium-ibogaine therapy in veterans with traumatic brain injuries. Nature Medicine, 2024. https://doi.org/10.1038/s41591-023-02705-w
  • Faerman A, et al. 12-month follow-up of magnesium-ibogaine therapy (MISTIC). Translational Psychiatry, 2026. https://doi.org/10.1038/s41398-026-04327-5
  • Davis AK, et al. American Journal of Drug and Alcohol Abuse, 2023. https://doi.org/10.1080/00952990.2023.2220874
  • Global Ibogaine Therapy Alliance. Clinical Guidelines for Ibogaine-Assisted Detoxification, v1.1, 2016. https://ibogaineguidelines.com/
  • MAPS. Ibogaine Investigator’s Brochure, v1, June 2026. https://maps.org/ibogaine/
  • VA release, 13 July 2026. https://news.va.gov/press-room/va-hhs-sign-mou-to-improve-cooperation-on-psychedelic-drug-trials/
  • Executive Order 14401, 18 April 2026. https://www.whitehouse.gov/presidential-actions/2026/04/accelerating-medical-treatments-for-serious-mental-illness/
  • Texas HHSC, ibogaine clinical trials. https://www.hhs.texas.gov/services/mental-health-substance-use/mental-health-substance-use-resources/ibogaine-clinical-trials

This page is general information, not medical advice. Treatment at IbogaQuest takes place only after a full medical evaluation. Medical and legal notice